Pentavalent vaccine A major breakthrough in India's Universal Immunization Program

被引:12
作者
Bairwa, Mohan [1 ]
Pilania, Manju [1 ]
Rajput, Meena [1 ]
Khanna, Pardeep [1 ]
Kumar, Neelam [1 ]
Nagar, Mukesh [1 ]
Chawla, Sumit [1 ]
机构
[1] Pt BD Sharma PGIMS, Rohtak, Haryana, India
关键词
immunization; DPT; pentavalent vaccine; hepatitis B; Haemophilus influenza type b; cost-effectiveness; immunogenicity; INFLUENZAE TYPE-B; HIB VACCINE; IMMUNOGENICITY; SAFETY; MENINGITIS; DIPHTHERIA; SCHEDULE; CHILDREN; INFANTS;
D O I
10.4161/hv.20651
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Immunization is one of the most important public health interventions and a cost effective strategy to control the infectious diseases especially in children. Complete immunization coverage in India has increased from below 20% in the 1980s to nearly 61% at present, but still more than 1/3rd children remain un-immunized. Advent of combination vaccines has facilitated incorporation of additional vaccines into immunization schedule. Pentavalent vaccine, against five killer diseases-diphtheria, pertussis, tetanus, hepatitis B and Hemophilus influenza type B (Hib), has been introduced in almost all GAVI eligible countries by 2011. Government of India introduced the vaccine in two states in pilot phase and has given green signal to six more states. The use of pentavalent vaccine automatically raises the coverage level of hepatitis B and Hib vaccines. If the vaccines are provided individually, the coverage of hepatitis B and Hib vaccines usually lags behind DPT coverage. This gap can be filled by using pentavalent vaccine in routine immunization programmes.
引用
收藏
页码:1314 / 1316
页数:3
相关论文
共 29 条
[1]   A multicenter, prospective, open-label, non-comparative study to evaluate the immunogenicity and tolerance of a new, fully liquid pentavalent vaccine (DTwP-HepB-Hib vaccine) [J].
Ali, S. Suhail ;
Chandrashekar, Sudha Rao ;
Singh, Meenu ;
Bansal, R. K. ;
Sharma, Deepika R. ;
Arora, Deepankar .
HUMAN VACCINES, 2007, 3 (04) :116-120
[2]  
[Anonymous], WORKING PAPER SERIES
[3]  
Bavdekar SB, 2007, INDIAN PEDIATR, V44, P505
[4]   The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule [J].
Chatterjee, Sukanta ;
Rego, Sylvan J. ;
D'Souza, Fulton ;
Bhatia, B. D. ;
Collard, Alix ;
Datta, Sanjoy K. ;
Jacquet, Jeanne-Marie .
BMC INFECTIOUS DISEASES, 2010, 10
[5]  
Chinchankar Nandita, 2002, Indian Pediatr, V39, P914
[6]   Nasopharyngeal carriage of Haemophilus influenzae [J].
Das B.K. ;
Arora N.K. ;
Mathur P. ;
Ostwal P. ;
Mandal S. ;
Kabra S.K. ;
Kapil A. ;
Lalitha M.K. ;
Thomas K. .
The Indian Journal of Pediatrics, 2002, 69 (9) :775-777
[7]  
Government of India, 2008, M NAT TECH ADV GROUP
[8]  
Gupta M, 2012, HLTH POLICY PLAN
[9]   Limiting infant exposure to thimerosal in vaccines and other sources of mercury [J].
Halsey, NA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (18) :1763-1766
[10]  
International Institute for Population and Sciences, 2010, DISTR LEV HOUS FAC S